TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | Payments of Dividends |
| Net income · 12 months | 706.00M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $706.00M | (m) |
| 2026-03-31 | (m) | $1.56B | (m) |
| 2025-12-31 | (m) | $1.41B | (m) |
| 2025-09-30 | (m) | $713.00M | (m) |
| 2025-06-30 | (m) | $-157.00M | (m) |
| 2025-03-31 | (m) | $-1.29B | (m) |
| 2024-12-31 | (m) | $-1.64B | (m) |
| 2024-09-30 | (m) | $-959.00M | (m) |
| 2024-06-30 | (m) | $-453.00M | (m) |
| 2024-03-31 | (m) | $-478.00M | (m) |
| 2023-12-31 | (m) | $-559.00M | (m) |
| 2023-09-30 | (m) | $-2.21B | (m) |
| 2023-06-30 | (m) | $-2.23B | (m) |
| 2023-03-31 | (m) | $-1.60B | (m) |
| 2022-12-31 | (m) | $-2.35B | (m) |
| 2022-09-30 | (m) | $-1.29B | (m) |
| 2022-06-30 | (m) | $-1.05B | (m) |
| 2022-03-31 | (m) | $-615.00M | (m) |
| 2021-12-31 | (m) | $417.00M | (m) |
| 2021-09-30 | (m) | $726.00M | (m) |
| 2021-06-30 | (m) | $-3.92B | (m) |
| 2021-03-31 | (m) | $-3.98B | (m) |
| 2020-12-31 | (m) | $-3.99B | (m) |
| 2020-09-30 | (m) | $-4.03B | (m) |
| 2020-06-30 | (m) | $4.00M | (m) |
| 2020-03-31 | (m) | $-825.00M | (m) |
| 2019-12-31 | (m) | $-999.00M | (m) |
| 2019-09-30 | (m) | $-3.99B | (m) |
| 2019-06-30 | (m) | $-3.89B | (m) |
| 2019-03-31 | (m) | $-3.38B | (m) |
| 2018-12-31 | (m) | $-2.15B | (m) |
| 2018-09-30 | (m) | $-10.80B | (m) |
| 2018-06-30 | (m) | $-10.00B | (m) |
| 2018-03-31 | (m) | $-15.79B | (m) |
| 2017-12-31 | (m) | $-16.27B | (m) |
| 2017-09-30 | (m) | $-5.70B | (m) |
| 2017-06-30 | (m) | $-5.89B | (m) |
| 2017-03-31 | (m) | $338.00M | (m) |
| 2016-12-31 | (m) | $329.00M | (m) |
| 2016-09-30 | (m) | $1.80B | (m) |
| 2016-06-30 | (m) | $1.49B | (m) |
| 2016-03-31 | (m) | $1.78B | (m) |
| 2015-12-31 | (m) | $1.59B | (m) |
| 2015-09-30 | (m) | $1.77B | (m) |
| 2015-06-30 | (m) | $2.55B | (m) |
| 2015-03-31 | (m) | $2.76B | (m) |
| 2014-12-31 | (m) | $3.06B | (m) |
| 2014-09-30 | (m) | $2.75B | (m) |
| 2014-06-30 | (m) | $2.58B | (m) |
| 2014-03-31 | (m) | $1.38B | (m) |
| 2013-12-31 | (m) | $1.27B | (m) |
| 2013-09-30 | (m) | $1.21B | (m) |
| 2013-06-30 | (m) | $419.00M | (m) |
| 2013-03-31 | (m) | $1.73B | (m) |
| 2012-12-31 | (m) | $1.96B | (m) |
| 2012-09-30 | (m) | $2.15B | (m) |
| 2012-06-30 | (m) | $3.14B | (m) |
| 2012-03-31 | (m) | $2.86B | (m) |
| 2011-12-31 | (m) | $2.76B | (m) |
| 2011-09-30 | (m) | $3.02B | (m) |
| 2011-06-30 | (m) | $3.16B | (m) |
| 2011-03-31 | (m) | $3.38B | (m) |
| 2010-12-31 | (m) | $3.33B | (m) |
| 2010-09-30 | $637.00M | $2.94B | 21.67% |
| 2010-06-30 | $596.00M | $2.54B | 23.48% |
| 2010-03-31 | $566.00M | $2.26B | 25.02% |
| 2009-12-31 | $528.00M | $2.00B | 26.40% |
| 2009-09-30 | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) |
| 2008-12-31 | $388.00M | $609.00M | 63.71% |
| 2008-09-30 | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) |
| 2008-03-31 | (m) | (m) | (m) |
| 2007-12-31 | $299.00M | $1.91B | 15.62% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.